SEARCH

SEARCH BY CITATION

References

  • Altschuler R. A., Monaghan D. T., Haser W. G., Wenthold R. J., Curthoys N. P. and Cotman C. W. (1985) Immunocytochemical localization of glutaminase-like and aspartate aminotransferase-like immunoreactivities in the rat and guinea pig hippocampus. Brain Res. 330, 225233.
  • Andrews-Zwilling Y., Bien-Ly N., Xu Q. et al. (2010) Apolipoprotein E4 causes age- and Tau-dependent impairment of GABAergic interneurons, leading to learning and memory deficits in mice. J. Neurosci. 30, 1370713717.
  • Bales K. R., Dodart J. C., DeMattos R. B., Holtzman D. M. and Paul S. M. (2002) Apolipoprotein E, amyloid, and Alzheimer disease. Mol. Interv., 2, 363375; 339.
  • Bell R. D., Winkler E. A., Singh I. et al. (2012) Apolipoprotein E controls cerebrovascular integrity via cyclophilin A. Nature 485, 512516.
  • Bour A., Grootendorst J., Vogel E., Kelche C., Dodart J. C., Bales K., Moreau P. H., Sullivan P. M. and Mathis C. (2008) Middle-aged human apoE4 targeted-replacement mice show retention deficits on a wide range of spatial memory tasks. Behav. Brain Res. 193, 174182.
  • Burbaeva G., Boksha I. S., Tereshkina E. B., Savushkina O. K., Starodubtseva L. I. and Turishcheva M. S. (2005) Glutamate metabolizing enzymes in prefrontal cortex of Alzheimer's disease patients. Neurochem. Res. 30, 14431451.
  • Burt T. D., Agan B. K., Marconi V. C. et al. (2008) Apolipoprotein (apo) E4 enhances HIV-1 cell entry in vitro, and the APOE epsilon4/epsilon4 genotype accelerates HIV disease progression. Proc. Natl Acad. Sci. USA 105, 87188723.
  • Chen Y., Durakoglugil M. S., Xian X. and Herz J. (2010) ApoE4 reduces glutamate receptor function and synaptic plasticity by selectively impairing ApoE receptor recycling. Proc. Natl Acad. Sci. USA 107, 1201112016.
  • Daniels R. W., Collins C. A., Chen K., Gelfand M. V., Featherstone D. E. and DiAntonio A. (2006) A single vesicular glutamate transporter is sufficient to fill a synaptic vesicle. Neuron 49, 1116.
  • Darna M., Schmutz I., Richter K., Yelamanchili S. V., Pendyala G., Holtje M., Albrecht U. and Ahnert-Hilger G. (2009) Time of day-dependent sorting of the vesicular glutamate transporter to the plasma membrane. J. Biol. Chem. 284, 43004307.
  • Desilva T. M., Borenstein N. S., Volpe J. J., Kinney H. C. and Rosenberg P. A. (2012) Expression of EAAT2 in neurons and protoplasmic astrocytes during human cortical development. J. Comp. Neurol. (in press) doi 10.1002/cne.23130.
  • Dumanis S. B., Tesoriero J. A., Babus L. W. et al. (2009) ApoE4 decreases spine density and dendritic complexity in cortical neurons in vivo. J. Neurosci. 29, 1531715322.
  • Filippini N., MacIntosh B. J., Hough M. G., Goodwin G. M., Frisoni G. B., Smith S. M., Matthews P. M., Beckmann C. F. and Mackay C. E. (2009) Distinct patterns of brain activity in young carriers of the APOE-epsilon4 allele. Proc. Natl Acad. Sci. USA 106, 72097214.
  • Grootendorst J., Bour A., Vogel E., Kelche C., Sullivan P. M., Dodart J. C., Bales K. and Mathis C. (2005) Human apoE targeted replacement mouse lines: h-apoE4 and h-apoE3 mice differ on spatial memory performance and avoidance behavior. Behav. Brain Res. 159, 114.
  • Heeren J., Grewal T., Laatsch A., Becker N., Rinninger F., Rye K. A. and Beisiegel U. (2004) Impaired recycling of apolipoprotein E4 is associated with intracellular cholesterol accumulation. J. Biol. Chem. 279, 5548355492.
  • Hunter J. M., Cirrito J. R., Restivo J. L. et al. (2012) Emergence of a seizure phenotype in aged apolipoprotein epsilon 4 targeted replacement mice. Brain Res., 1467, 120132.
  • Ji Y., Gong Y., Gan W., Beach T., Holtzman D. M. and Wisniewski T. (2003) Apolipoprotein E isoform-specific regulation of dendritic spine morphology in apolipoprotein E transgenic mice and Alzheimer's disease patients. Neuroscience 122, 305315.
  • Kanai Y. and Hediger M. A. (1992) Primary structure and functional characterization of a high-affinity glutamate transporter. Nature 360, 467471.
  • Kanamori K., Ross B. D. and Kondrat R. W. (1998) Rate of glutamate synthesis from leucine in rat brain measured in vivo by 15N NMR. J. Neurochem. 70, 13041315.
  • Kariv-Inbal Z., Yacobson S., Berkecz R., Peter M., Janaky T., Lutjohann D., Broersen L. M., Hartmann T. and Michaelson D. M. (2012) The isoform-specific pathological effects of apoE4 in vivo are prevented by a fish oil (DHA) diet and are modified by cholesterol. J. Alzheimers Dis. 28, 667683.
  • Khandelwal P. J., Herman A. M., Hoe H. S., Rebeck G. W. and Moussa C. E. (2011) Parkin mediates beclin-dependent autophagic clearance of defective mitochondria and ubiquitinated Abeta in AD models. Hum. Mol. Genet. 20, 20912102.
  • Korwek K. M., Trotter J. H., Ladu M. J., Sullivan P. M. and Weeber E. J. (2009) ApoE isoform-dependent changes in hippocampal synaptic function. Mol. Neurodegener. 4, 21.
  • Kvamme E., Torgner I. A. and Roberg B. (2001) Kinetics and localization of brain phosphate activated glutaminase. J. Neurosci. Res. 66, 951958.
  • Laake J. H., Slyngstad T. A., Haug F. M. and Ottersen O. P. (1995) Glutamine from glial cells is essential for the maintenance of the nerve terminal pool of glutamate: immunogold evidence from hippocampal slice cultures. J. Neurochem. 65, 871881.
  • Lebon V., Petersen K. F., Cline G. W., Shen J., Mason G. F., Dufour S., Behar K. L., Shulman G. I. and Rothman D. L. (2002) Astroglial contribution to brain energy metabolism in humans revealed by 13C nuclear magnetic resonance spectroscopy: elucidation of the dominant pathway for neurotransmitter glutamate repletion and measurement of astrocytic oxidative metabolism. J. Neurosci. 22, 15231531.
  • Lobo A. C., Gomes J. R., Catarino T. et al. (2011) Cleavage of the vesicular glutamate transporters under excitotoxic conditions. Neurobiol. Dis. 44, 292303.
  • Maragakis N. J., Dietrich J., Wong V., Xue H., Mayer-Proschel M., Rao M. S. and Rothstein J. D. (2004) Glutamate transporter expression and function in human glial progenitors. Glia 45, 133143.
  • Nishitsuji K., Hosono T., Nakamura T., Bu G. and Michikawa M. (2011) Apolipoprotein E regulates the integrity of tight junctions in an isoform-dependent manner in an in vitro blood-brain barrier model. J. Biol. Chem., 286(1753), 617542.
  • Ponomareva N. V., Korovaitseva G. I. and Rogaev E. I. (2008) EEG alterations in non-demented individuals related to apolipoprotein E genotype and to risk of Alzheimer disease. Neurobiol. Aging 29, 819827.
  • Reiman E. M., Caselli R. J., Yun L. S., Chen K., Bandy D., Minoshima S., Thibodeau S. N. and Osborne D. (1996) Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. N. Engl. J. Med. 334, 752758.
  • Reiman E. M., Caselli R. J., Chen K., Alexander G. E., Bandy D. and Frost J. (2001) Declining brain activity in cognitively normal apolipoprotein E epsilon 4 heterozygotes: a foundation for using positron emission tomography to efficiently test treatments to prevent Alzheimer's disease. Proc. Natl Acad. Sci. USA 98, 33343339.
  • Reiman E. M., Chen K., Alexander G. E., Caselli R. J., Bandy D., Osborne D., Saunders A. M. and Hardy J. (2004) Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia. Proc. Natl Acad. Sci. USA 101, 284289.
  • Robinson S. R. (2001) Changes in the cellular distribution of glutamine synthetase in Alzheimer's disease. J. Neurosci. Res. 66, 972980.
  • Rothstein J. D., Martin L., Levey A. I., Dykes-Hoberg M., Jin L., Wu D., Nash N. and Kuncl R. W. (1994) Localization of neuronal and glial glutamate transporters. Neuron 13, 713725.
  • Savva G. M. and Stephan B. C. (2010) Epidemiological studies of the effect of stroke on incident dementia: a systematic review. Stroke 41, e41e46.
  • Scarmeas N., Habeck C. G., Hilton J., Anderson K. E., Flynn J., Park A. and Stern Y. (2005) APOE related alterations in cerebral activation even at college age. J. Neurol. Neurosurg. Psychiatry 76, 14401444.
  • Shashidharan P., Huntley G. W., Meyer T., Morrison J. H. and Plaitakis A. (1994) Neuron-specific human glutamate transporter: molecular cloning, characterization and expression in human brain. Brain Res. 662, 245250.
  • Small G. W., Mazziotta J. C., Collins M. T. et al. (1995) Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease. JAMA 273, 942947.
  • Sullivan P. M., Mezdour H., Aratani Y., Knouff C., Najib J., Reddick R. L., Quarfordt S. H. and Maeda N. (1997) Targeted replacement of the mouse apolipoprotein E gene with the common human APOE3 allele enhances diet-induced hypercholesterolemia and atherosclerosis. J. Biol. Chem. 272, 1797217980.
  • Sullivan P. M., Mezdour H., Quarfordt S. H. and Maeda N. (1998) Type III hyperlipoproteinemia and spontaneous atherosclerosis in mice resulting from gene replacement of mouse Apoe with human Apoe*2. J. Clin. Invest. 102, 130135.
  • Takamori S. (2006) VGLUTs: ‘exciting’ times for glutamatergic research? Neurosci. Res. 55, 343351.
  • Takamori S., Rhee J. S., Rosenmund C. and Jahn R. (2000) Identification of a vesicular glutamate transporter that defines a glutamatergic phenotype in neurons. Nature 407, 189194.
  • Trommer B. L., Shah C., Yun S. H. et al. (2004) ApoE isoform affects LTP in human targeted replacement mice. NeuroReport 15, 26552658.
  • Trommer B. L., Shah C., Yun S. H. et al. (2005) ApoE isoform-specific effects on LTP: blockade by oligomeric amyloid-beta1-42. Neurobiol. Dis. 18, 7582.
  • Wang C., Wilson W. A., Moore S. D., Mace B. E., Maeda N., Schmechel D. E. and Sullivan P. M. (2005) Human apoE4-targeted replacement mice display synaptic deficits in the absence of neuropathology. Neurobiol. Dis. 18, 390398.
  • Wilson N. R., Kang J., Hueske E. V., Leung T., Varoqui H., Murnick J. G., Erickson J. D. and Liu G. (2005) Presynaptic regulation of quantal size by the vesicular glutamate transporter VGLUT1. J. Neurosci. 25, 62216234.
  • Wojcik S. M., Rhee J. S., Herzog E., Sigler A., Jahn R., Takamori S., Brose N. and Rosenmund C. (2004) An essential role for vesicular glutamate transporter 1 (VGLUT1) in postnatal development and control of quantal size. Proc. Natl Acad. Sci. USA 101, 71587163.
  • Yelamanchili S. V., Pendyala G., Brunk I., Darna M., Albrecht U. and Ahnert-Hilger G. (2006) Differential sorting of the vesicular glutamate transporter 1 into a defined vesicular pool is regulated by light signaling involving the clock gene Period2. J. Biol. Chem. 281, 1567115679.
  • Zhou W., Xu D., Peng X., Zhang Q., Jia J. and Crutcher K. A. (2008) Meta-analysis of APOE4 allele and outcome after traumatic brain injury. J. Neurotrauma 25, 279290.